Acadia Healthcare [ACHC] vs Chemed [CHE] Detailed Stock Comparison

Acadia Healthcare Company, Inc.

NASDAQ
Loading...

Chemed Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Acadia Healthcare Company, Inc. wins in 8 metrics, Chemed Corporation wins in 12 metrics, with 0 ties. Chemed Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Acadia Healthcare Company, Inc. Chemed Corporation Better
P/E Ratio (TTM) 20.57 20.88 Acadia Healthcare Company, Inc.
Price-to-Book Ratio 1.27 5.36 Acadia Healthcare Company, Inc.
Debt-to-Equity Ratio 124.03 14.68 Chemed Corporation
PEG Ratio -0.01 -2.12 Acadia Healthcare Company, Inc.
EV/EBITDA 9.08 13.21 Acadia Healthcare Company, Inc.
Profit Margin (TTM) -33.29% 10.48% Chemed Corporation
Operating Margin (TTM) 5.80% 16.62% Chemed Corporation
EBITDA Margin (TTM) 5.80% 16.62% Chemed Corporation
Return on Equity -40.96% 25.28% Chemed Corporation
Return on Assets (TTM) 4.22% 13.40% Chemed Corporation
Free Cash Flow (TTM) $-439.91M $325.48M Chemed Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 2.47% -25.82% Acadia Healthcare Company, Inc.
Price-to-Sales Ratio (TTM) 0.76 2.03 Acadia Healthcare Company, Inc.
Enterprise Value $5.24B $5.34B Chemed Corporation
EV/Revenue Ratio 1.58 2.11 Acadia Healthcare Company, Inc.
Gross Profit Margin (TTM) 96.26% 35.22% Acadia Healthcare Company, Inc.
Revenue per Share (TTM) $37 $176 Chemed Corporation
Earnings per Share (Diluted) $-12.16 $18.34 Chemed Corporation
Beta (Stock Volatility) 0.71 0.48 Chemed Corporation
Short % of Float 37.08% 4.26% Chemed Corporation

Acadia Healthcare Company, Inc. vs Chemed Corporation Stock Performance Analysis

Loading Price Chart...

ACHC
CHE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Acadia Healthcare Company, Inc.5.36%3.96%-11.81%4.18%48.09%70.89%
Chemed Corporation2.36%-4.60%-2.04%-0.99%-2.87%-1.55%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Acadia Healthcare Company, Inc.2.47%-66.61%-64.63%-61.24%102.09%163.64%
Chemed Corporation-25.82%-21.43%-14.46%221.65%544.03%685.29%

Performance & Financial Health Analysis: Acadia Healthcare Company, Inc. vs Chemed Corporation

MetricACHCCHE
Market Information
Market Cap i$2.52B$5.65B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i2,798,512222,026
90 Day Avg. Volume i2,906,871264,265
Last Close$25.73$427.06
52 Week Range$11.43 - $30.20$365.21 - $570.34
% from 52W High-14.80%-25.12%
All-Time High$89.85 (Nov 28, 2022)$654.62 (Mar 11, 2024)
% from All-Time High-71.36%-34.76%
Growth Metrics
Quarterly Revenue Growth0.06%0.00%
Quarterly Earnings Growth0.06%-0.15%
Financial Health
Profit Margin (TTM) i-0.33%0.10%
Operating Margin (TTM) i0.06%0.17%
Return on Equity (TTM) i-0.41%0.25%
Debt to Equity (MRQ) i124.0314.68
Cash & Liquidity
Book Value per Share (MRQ)$21.55$71.44
Cash per Share (MRQ)$1.45$5.41
Operating Cash Flow (TTM) i$131.90M$388.27M
Levered Free Cash Flow (TTM) i$-370,052,864$246.01M
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$2.30

Valuation & Enterprise Metrics Analysis: Acadia Healthcare Company, Inc. vs Chemed Corporation

MetricACHC (Apr 24, 2026)CHE (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i20.5720.88
Forward P/E i16.3714.39
PEG Ratio i-0.01-2.12
Price to Sales (TTM) i0.762.03
Price to Book (MRQ) i1.275.36
Market Capitalization
Market Capitalization i$2.52B$5.65B
Enterprise Value i$5.24B$5.34B
Enterprise Value Metrics
Enterprise to Revenue i1.582.11
Enterprise to EBITDA i9.0813.21
Risk & Other Metrics
Beta i0.710.48
Book Value per Share (MRQ) i$21.55$71.44

Financial Statements Comparison: Acadia Healthcare Company, Inc. vs Chemed Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricACHC (2025)CHE (2025)
Revenue/Sales i3.31B2.53B
Cost of Goods Sold i118.05M1.71B
COGS % of Revenue i3.6%67.5%
Gross Profit i3.19B823.18M
Gross Margin i96.4%32.5%
Research & Development iN/AN/A
Operating Income (EBIT) i387.97M341.16M
Operating Margin i11.7%13.5%
EBITDA i577.21M425.28M
EBITDA Margin i17.4%16.8%
Pre-Tax Income i-1.07B355.78M
Pre-Tax Income % of Revenue i-32.2%14.1%
Income Tax i25.98M90.54M
Income Tax % of Revenue i0.8%3.6%
Net Income (Profit) i-1.09B265.24M
Profit Margin i-33.0%10.5%

Balance Sheet & Liquidity Metrics

MetricACHC (2025)CHE (2025)
Cash & Equivalents i133.24M74.52M
Total Current Assets i814.14M302.62M
Total Current Assets % of Revenue i24.6%12.0%
Total Current Liabilities i525.19M287.13M
Total Current Liabilities % of Revenue i15.9%11.3%
Long-Term Debt i2.59B102.87M
Long-Term Debt % of Revenue i78.3%4.1%
Total Shareholders Equity i2.14B979.41M
Retained Earnings i-765.84M2.96B
Retained Earnings % of Revenue i-23.1%116.8%
Property, Plant & Equipment i642.19M131.15M

Cash Flow Statement Comparison

MetricACHC (2025)CHE (2025)
Operating Cash Flow i-895.23M383.11M
Operating Cash Flow % of Revenue i-27.0%15.1%
Capital Expenditures i23.85M4.57M
Free Cash Flow i-439.91M325.48M
FCF Margin i-13.3%12.9%
Debt Repayment i-1.72B0
Common Stock Repurchase i-50.03M-431.50M

Short Interest & Institutional Ownership Analysis

MetricACHCCHE
Shares Short i22.08M487,863
Short Ratio i7.061.62
Short % of Float i37.08%4.26%
Shares Outstanding i90.45M13.71M
Float Shares i83.22M13.53M
% Held by Insiders i1.43%1.87%
% Held by Institutions i135.64%98.39%
% Held by Public i-37.07%-0.26%

Dividend Analysis & Yield Comparison: Acadia Healthcare Company, Inc. vs Chemed Corporation

MetricACHCCHE
Last 12-Month Dividend iN/A$2.30
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$1.93
3-Year Avg Dividend Yield iN/A0.09%
3-Year Total Dividends iN/A$5.78
Ex-Dividend DateN/AFeb 23, 2026